Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Capital Employed (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Capital Employed for 6 consecutive years, with 0.69% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Capital Employed fell 29.0% to 0.69% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.69%, a 29.0% decrease, with the full-year FY2024 number at 0.54%, down 8.0% from a year prior.
  • Return on Capital Employed was 0.69% for Q1 2025 at Pliant Therapeutics, down from 0.44% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.27% in Q1 2021 to a low of 0.69% in Q1 2025.
  • A 5-year average of 0.4% and a median of 0.37% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: plummeted -46bps in 2021, then rose 23bps in 2023.
  • Pliant Therapeutics' Return on Capital Employed stood at 0.46% in 2021, then grew by 19bps to 0.37% in 2022, then grew by 1bps to 0.37% in 2023, then decreased by -19bps to 0.44% in 2024, then crashed by -56bps to 0.69% in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Return on Capital Employed are 0.69% (Q1 2025), 0.44% (Q2 2024), and 0.4% (Q1 2024).